日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of 3 commercial assays for the measurement of tissue factor activity in human plasma.

对 3 种用于测量人血浆中组织因子活性的商业检测方法进行评价。

Sachetto Ana T A, Monroe Dougald M, Mackman Nigel

Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model.

利用小鼠模型探讨镰状细胞性状中静脉血栓形成和慢性肾脏疾病的病理生理学

Trebak Fatima, Sako Mohammad O, Grover Steven P, Seanoon Karnsasin, Pawlinski Izabela, Moonla Chatphatai, Henderson Michael W, Derebail Vimal K, Monroe Dougald M, Ellsworth Patrick, Pawlinski Rafal, Kasztan Malgorzata, Key Nigel S

Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions

emicizumab的数学分析:亲和力驱动的复合物形成和脂质-表面反应

Madrigal, Jamie; Monroe, Dougald M; Sindi, Suzanne S; Leiderman, Karin

Mechanisms of thrombin inhibition by protein S and the TFPIα-fVshort-protein S complex

蛋白S和TFPIα-fVshort-蛋白S复合物抑制凝血酶的机制

Ginsberg, Alexander G; Ahnström, Josefin; Crawley, James T B; Leiderman, Karin; Monroe, Dougald M; Neeves, Keith B; Sindi, Suzanne F; Fogelson, Aaron L

The kinetics and interplay of thrombin inhibition by 4 plasma proteinase inhibitors

4种血浆蛋白酶抑制剂对凝血酶抑制的动力学和相互作用

Ma, Allen; Monroe, Dougald M; Hoffman, Maureane

Blood coagulation factor IX: structural insights impacting hemophilia B therapy

血液凝固因子IX:影响B型血友病治疗的结构见解

Bos, Mettine H A; van Diest, Rianne E; Monroe, Dougald M

Hypertonicity and/or acidosis induce marked rheological changes under hypoxic conditions in sickle trait red blood cells

在缺氧条件下,高渗和/或酸中毒可引起镰状细胞性状红细胞流变学的显著变化。

Ellsworth, Patrick; Pawlinski, Izabela J; Sielaty, Rachel; Ilich, Anton; Prokopenko, Yuriy; Moonla, Chatphatai; Monroe, Dougald M; Pawlinski, Rafal; Key, Nigel S

Mathematical modeling identifies clotting factor combinations that modify thrombin generation in normal and factor VIII-, IX-, or XI-deficient blood

数学模型可以识别出能够改变正常血液和缺乏因子VIII、IX或XI血液中凝血酶生成的凝血因子组合。

Stobb, Michael T; Neeves, Keith B; Monroe, Dougald M; Sindi, Suzanne S; Leiderman, Karin; Fogelson, Aaron L

Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency

组织因子途径抑制剂是因子XI缺乏症出血风险的潜在调节因子。

Reitsma, Stéphanie E; Holle, Lori A; Bouck, Emma G; Monroe, Dougald M; Mast, Alan E; Burthem, John; Bolton-Maggs, Paula H B; Gidley, Gillian N; Wolberg, Alisa S

Computationally Driven Discovery in Coagulation

凝血过程中的计算驱动发现

Link, Kathryn G; Stobb, Michael T; Monroe, Dougald M; Fogelson, Aaron L; Neeves, Keith B; Sindi, Suzanne S; Leiderman, Karin